RFX6 and diabetes mellitus: Human pluripotent stem cells have been extensively used to model monogenic diabetes genes [25], including RFX6 [9, 26, 27], as they can be differentiated into stem-cell-derived islets (SC-islets) that closely mimic native human islets developmentally and functionally.